表紙
市場調查報告書

注意力不足過動症(簡稱過動症)(ADHD)市場:藥物類型,人口統計,流通管道,各地區的分析,規模,佔有率,趨勢,預測(2020年∼2026年)

Attention Deficit Hyperactivity Disorder Market, By Drug Type, By Demographics, By Distribution Channel, and By Geography - Analysis, Size, Share, Trends, & Forecast from 2020-2026

出版商 AnalystView Market Insights 商品編碼 941370
出版日期 內容資訊 英文 177 Pages
商品交期: 2-3個工作天內
價格
注意力不足過動症(簡稱過動症)(ADHD)市場:藥物類型,人口統計,流通管道,各地區的分析,規模,佔有率,趨勢,預測(2020年∼2026年) Attention Deficit Hyperactivity Disorder Market, By Drug Type, By Demographics, By Distribution Channel, and By Geography - Analysis, Size, Share, Trends, & Forecast from 2020-2026
出版日期: 2020年06月01日內容資訊: 英文 177 Pages
簡介

全球注意力不足過動症(簡稱過動症)(ADHD)市場在2019年估算為1,632萬美金。該市場在2020年∼2026年的預測期間內,預計將以5.9%的年複合成長率增長。

本報告提供全球注意力不足過動症(簡稱過動症)(ADHD)市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,藥品類型·人口統計·流通管道·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 市場概要

第2章 摘要整理

  • 市場區隔
    • 各藥物類型
    • 人口統計別
    • 各流通管道
    • 各地區
  • 競爭考察

第3章 主要市場趨勢

  • 市場成長要素
  • 阻礙市場要素
  • 市場機會
  • 市場未來趨勢

第4章 產業調查

  • 波特的五力分析
  • 行銷策略分析
  • 成長預測製圖
  • 法規結構分析
  • COVID-19影響分析

第5章 市場形勢

  • 市場佔有率分析
  • 主要的創新者
  • 各主要製造商的明細資料
    • 現有企業分析
    • 新興企業分析

第6章 市場分析:各藥物類型

  • 概況
    • 市場區隔佔有率分析
  • 非刺激藥
  • 刺激藥

第7章 市場分析:各人口統計

  • 概況
    • 市場區隔佔有率分析
  • 兒童
  • 大人(18歲以上)

第8章 市場分析:各流通管道

  • 概況
    • 市場區隔佔有率分析
  • 醫院藥局
  • 線上管道
  • 零售藥局

第9章 市場分析:各地區

  • 簡介
    • 市場區隔佔有率分析
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第10章 供應商分析

  • Eli Lily & Company
  • Novartis AG
  • Johnson & Johnson Services, LLC
  • Pfizer, Inc.
  • Lupin Limited
  • Mallinckrodt Pharmaceuticals
  • Shire plc
  • NEOS Therapeutics Inc.
  • Prude Pharma L.P.

第11章 分析師的見解

第12章 附錄

  • 調查手法
  • 參考文獻
  • 簡稱
  • 免責聲明
  • 諮詢方式
目錄

REPORT HIGHLIGHT

Attention deficit hyperactivity disorder (ADHD) market was valued at USD 16.32 million by 2019, growing with 5.9% CAGR during the forecast period, 2020-2026.

Attention-deficit hyperactivity disorder or ADHD is a medical condition, in which there is a continuing pattern of hyperactivity-impulsivity or inattention that interferes with the development or functioning of the brain. A person suffering from ADHD has differences in brain activity and brain development that affects attentiveness, self-control, and the ability to sit still.

Market Dynamics

The growing prevalence of ADHD, increasing use of additives & preservatives in children's diet, and growing awareness regarding mental health amongst the general population are the major factors boosting the growth of global attention deficit hyperactivity disorder (ADHD) market. According to the Centers for Disease Control & Prevention (CDC), around 6.1 million children in the U.S. were diagnosed with ADHD in 2016 and this number is estimated to increase by the end of 2030. Furthermore, the increasing pharmaceutical R&D spending and rising healthcare infrastructure are anticipated to propel the market growth. Conversely, the under diagnoses of ADHD owing to the presence of comorbid conditions in children and side effects & contradictions related to ADHD are predicted to hamper the market growth in the coming future. On the contrary, the rise in the number of novel drug approvals and various product launches all across the globe are expected to create lucrative growth opportunities in the overall market during the forecast period.

Drug Type Takeaway

Based on the drug type, the worldwide ADHD market is bifurcated into non-stimulant and stimulant. The non-stimulant drugs include guanfacine, atomoxetine, bupropion, and clonidine. Whereas, the stimulant drugs include amphetamine, lisdexamfetamine, methylphenidate, and dexmethylphenidate.

The stimulant drug type segment registered for the majority of share in 2019 and is anticipated to dominate the industry throughout the forecast. This dominance is majorly attributed to the growing demand for these drugs owing to their effectiveness for treating symptoms of ADHD and the support of governments all across the globe for making use of stimulants in treating mental health disorders. On the other hand, the non-stimulant segment is projected to witness the fastest growth during the period of forecast owing to its long-lasting effect. In addition, as non-stimulant drugs do not present any risk of substance abuse is another factor impelling the segmental market growth.

Demographic Takeaway

Based on the demographics, the overall ADHD market is categorized into children and adults. Of these, the adult segment accounted for the largest market share in 2019 and is estimated to grow at a significant pace in the projected timeframe. This growth is majorly owing to the rising prevalence of ADHD in adults and the presence of a large patient pool population all across the globe. According to the statistics provided by the CDC, the prevalence of ADHD in adults is estimated at 2.5% all across the globe. About 4.4% of the adult population in the U.S. is diagnosed with ADHD every year.

Distribution Channel Takeaway

Based on the distribution channel, the global market for ADHD is bifurcated into retail and hospital pharmacy. Of these, the retail pharmacy segment registered for the majority of share in the market in 2019 owing to the increase in the number of patient care initiatives and the rising number of prescriptions by retail pharmacies. The number of ADHD inpatients is fewer in number when compared with the number of patients in homecare settings. This is because of the lengthy nature of the treatment of ADHD medical conditions. Besides, patients prefer purchasing drugs from the retail pharmacies, which is expected to drive the segmental market growth during the forecast period.

REGIONAL TAKEAWAY

Depending on the region, the global industry is divided into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The North American region played a dominant role in the ADHD market in 2019 and is anticipated to continue its dominance throughout the forecast. This is majorly owing to the rise in the number of product launches, a large volume of drug prescriptions, and the presence of major market players in this region.

On the other hand, the European market for ADHD is projected to grow at the fastest pace in the period of forecast owing to the growing awareness amongst people regarding mental health and rising incidence of ADHD in this region. In addition, the presence of enhanced healthcare facilities for treatment and high consumption of additives & preservative are other factors expected to impel the segmental market growth in the coming future.

COVID-19 Impact

The sudden outbreak of the COVID-19 pandemic is certainly a hard time for individuals suffering from attention-deficit hyperactivity disorder (ADHD). The global ADHD market is thus, likely to witness positive growth during these uncertain times. Furthermore, the panic buying state of consumers for essential medicines as a precautionary measure has resulted in medicines going out of stock. Therefore, the major market players are investing more in R&D activities and novel drug developments in order to sustain in this pandemic.

KEY VENDOR TAKEAWAY

The leading players operating in the global attention deficit hyperactivity disorder (ADHD) market include Eli Lily & Company, Novartis AG, Johnson & Johnson Services, LLC, Pfizer, Lupin, Mallinckrodt, Shire, NEOS Therapeutics Inc., and Prude Pharma L.P. These players are adopting several strategies such as mergers, acquisitions, R&D activities, and product launches to hold a strong position in the global industry.

For instance, in September 2018, Tris Pharma acquired Pfizer's NextWave Pharmaceuticals to develop a treatment for attention-deficit hyperactivity disorder. The company has used its LiquiXR platform to co-develop ADHD treatment with NextWave.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year - 2015 to2018

Base Year - 2019

Estimated Year - 2020

Projected Year - 2026

TARGET AUDIENCE

Traders, Distributors, and Suppliers

Manufacturers

Government and Regional Agencies

Research Organizations

Consultants

Distributors

Scope of the Report

The scope of this report covers the market by its major segments, which include as follows:

ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) MARKET KEY PLAYERS

Johnson & Johnson Services, LLC

Pfizer, Inc.

Lupin Limited

Eli Lily & Company

Novartis AG

Mallinckrodt Pharmaceuticals

Shire plc

NEOS Therapeutics Inc.

Prude Pharma L.P.

ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) MARKET, BY DRUG TYPE

Non-stimulant Drugs

Guanfacine

Atomoxetine

Bupropion

Clonidine

Stimulant Drugs

Amphetamine

Lisdexamfetamine

Methylphenidate

Exmethylphenidate

ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) MARKET, BY DEMOGRAPHIC

Children

Adult (Aged 18 and above)

ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) MARKET, BY DITRIBUTION CHANNEL

Hospital Pharmacy

Retail Pharmacy

Online Channel

Others

ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Drug Type
    • 2.1.2. Market Snippet by Demographic
    • 2.1.3. Market Snippet by Distribution Channel
    • 2.1.4. Market Snippet by Region
  • 2.2. Competitive Insights

3. ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) INDUSTRY STUDY

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis
  • 4.5. COVID-19 Impact Analysis
    • 4.5.1. Pre-COVID-19 Impact Analysis
    • 4.5.2. Post-COVID-19 Impact Analysis

5. ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) MARKET LANDSCAPE

  • 5.1. Market Share Analysis
  • 5.2. Key Innovators
  • 5.3. Breakdown Data, by Key manufacturer
    • 5.3.1. Established Player Analysis
    • 5.3.2. Emerging Player Analysis

6. ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) MARKET - BY DRUG TYPE

  • 6.1. Overview
    • 6.1.1. Segment Share Analysis, By Drug Type, 2019 & 2026 (%)
  • 6.2. Non-stimulant Drugs
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.2.2.1. Guanfacine
      • 6.2.2.1.1. Overview
      • 6.2.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.2.2.2. Atomoxetine
      • 6.2.2.2.1. Overview
      • 6.2.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.2.2.3. Bupropion
      • 6.2.2.3.1. Overview
      • 6.2.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.2.2.4. Clonidine
      • 6.2.2.4.1. Overview
      • 6.2.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.3. Stimulant Drugs
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.3.2.1. Amphetamine
      • 6.3.2.1.1. Overview
      • 6.3.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.3.2.2. Lisdexamfetamine
      • 6.3.2.2.1. Overview
      • 6.3.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.3.2.3. Methylphenidate
      • 6.3.2.3.1. Overview
      • 6.3.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.3.2.4. Exmethylphenidate
      • 6.3.2.4.1. Overview
      • 6.3.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7. ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) MARKET - BY DEMOGRAPHIC

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Type, 2019 & 2026 (%)
  • 7.2. Children
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.3. Adult (Aged 18 and above)
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

8. ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) MARKET - BY DISTRIBUTION CHANNEL

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Distribution Channel, 2019 & 2026 (%)
  • 8.2. Hospital Pharmacy
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.3. Online Channel
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.4. Retail Pharmacy
    • 8.4.1. Overview
    • 8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9. ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) MARKET- BY GEOGRAPHY

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Drug Type, 2015 - 2026 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Demographic, 2015 - 2026 (US$ Million)
    • 9.2.6. North America Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.2.7. U.S.
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.2.8. Canada
      • 9.2.8.1. Overview
      • 9.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Drug Type, 2015 - 2026 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Demographic, 2015 - 2026 (US$ Million)
    • 9.3.6. Europe Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.3.7. Germany
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.8. Italy
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.9. United Kingdom
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.10. France
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.11. Rest of Europe
      • 9.3.11.1. Overview
      • 9.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2015 - 2026 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Demographic, 2015 - 2026 (US$ Million)
    • 9.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.4.7. India
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.8. China
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.10. South Korea
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.11. Rest of APAC
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Drug Type, 2015 - 2026 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Demographic, 2015 - 2026 (US$ Million)
    • 9.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.5.7. Brazil
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.5.8. Mexico
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.5.9. Argentina
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2015 - 2026 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Demographic, 2015 - 2026 (US$ Million)
    • 9.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.6.7. Saudi Arabia
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.6.8. United Arab Emirates
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

10. KEY VENDOR ANALYSIS

  • 10.1. Eli Lily & Company
    • 10.1.1. Company Snapshot
    • 10.1.2. Financial Performance
    • 10.1.3. Drug Type Benchmarking
    • 10.1.4. Strategic Initiatives
  • 10.2. Novartis AG
  • 10.3. Johnson & Johnson Services, LLC
  • 10.4. Pfizer, Inc.
  • 10.5. Lupin Limited
  • 10.6. Mallinckrodt Pharmaceuticals
  • 10.7. Shire plc
  • 10.8. NEOS Therapeutics Inc.
  • 10.9. Prude Pharma L.P.

11. 360 DEGREE ANALYSTVIEW

12. APPENDIX

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Attention Deficit Hyperactivity Disorder (ADHD) market: Distribution Channelnapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Type
  • TABLE Global Attention Deficit Hyperactivity Disorder (ADHD) market, by Drug Type 2015-2026 (USD Million)
  • TABLE Attention Deficit Hyperactivity Disorder (ADHD) market: Demographic Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Demographic
  • TABLE Global Attention Deficit Hyperactivity Disorder (ADHD) market, by Demographic 2015-2026 (USD Million)
  • TABLE Attention Deficit Hyperactivity Disorder (ADHD) market: Distribution Channel Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Attention Deficit Hyperactivity Disorder (ADHD) market, by Distribution Channel2015-2026 (USD Million)
  • TABLE Attention Deficit Hyperactivity Disorder (ADHD) market: RegionalSnapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Attention Deficit Hyperactivity Disorder (ADHD) market, by Region 2015-2026 (USD Million)
  • TABLE North America Attention Deficit Hyperactivity Disorder (ADHD) market, by Country, 2015-2026 (USD Million)
  • TABLE North America Attention Deficit Hyperactivity Disorder (ADHD) market, by Drug Type, 2015-2026 (USD Million)
  • TABLE North America Attention Deficit Hyperactivity Disorder (ADHD) market, by Demographic, 2015-2026 (USD Million)
  • TABLE North America Attention Deficit Hyperactivity Disorder (ADHD) market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE Europe Attention Deficit Hyperactivity Disorder (ADHD) market, by Country, 2015-2026 (USD Million)
  • TABLE Europe Attention Deficit Hyperactivity Disorder (ADHD) market, by Drug Type, 2015-2026 (USD Million)
  • TABLE Europe Attention Deficit Hyperactivity Disorder (ADHD) market, by Demographic, 2015-2026 (USD Million)
  • TABLE Europe Attention Deficit Hyperactivity Disorder (ADHD) market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) market, by Country, 2015-2026 (USD Million)
  • TABLE Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) market, by Drug Type, 2015-2026 (USD Million)

TABLEAsia Pacific Attention Deficit Hyperactivity Disorder (ADHD) market, by Demographic, 2015-2026 (USD Million)

  • TABLE Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE Latin America Attention Deficit Hyperactivity Disorder (ADHD) market, by Country, 2015-2026 (USD Million)
  • TABLE Latin America Attention Deficit Hyperactivity Disorder (ADHD) market, by Drug Type, 2015-2026 (USD Million)
  • TABLE Latin America Attention Deficit Hyperactivity Disorder (ADHD) market, by Demographic, 2015-2026 (USD Million)
  • TABLE Latin America Attention Deficit Hyperactivity Disorder (ADHD) market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) market, by Country, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) market, by Drug Type, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) market, by Demographic, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) market, by Distribution Channel, 2015-2026 (USD Million)

List of Figures

  • FIGURE Attention Deficit Hyperactivity Disorder (ADHD) market segmentation
  • FIGURE Market Research Methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2018
  • FIGURE Drug Type segment market share analysis, 2019 & 2026
  • FIGURE Drug Type segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Non-stimulant Drugs market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Guanfacine market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Atomoxetine market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Bupropion market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Clonidine market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Stimulant Drugs market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Amphetamine market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Lisdexamfetamine market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Methylphenidate market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Dexmethylphenidate market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Demographic segment market share analysis, 2019 & 2026
  • FIGURE Demographic segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Children market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Adult (Aged 18 and above) market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2019 & 2026
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Hospital Pharmacy market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Online Channel market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Retail Pharmacy market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Regional segment market share analysis, 2019 & 2026
  • FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE North America Attention Deficit Hyperactivity Disorder (ADHD) market share and leading players, 2018
  • FIGURE Europe Attention Deficit Hyperactivity Disorder (ADHD) market share and leading players, 2018
  • FIGURE Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) market share and leading players, 2018
  • FIGURE Latin America Attention Deficit Hyperactivity Disorder (ADHD) market share and leading players, 2018
  • FIGURE Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) market share and leading players, 2018
  • FIGURE North America Attention Deficit Hyperactivity Disorder (ADHD) market share analysis by country, 2018
  • FIGURE U.S. Attention Deficit Hyperactivity Disorder (ADHD) Market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Canada Attention Deficit Hyperactivity Disorder (ADHD) Market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Europe Attention Deficit Hyperactivity Disorder (ADHD) Market share analysis by country, 2018
  • FIGURE Germany Attention Deficit Hyperactivity Disorder (ADHD) market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Spain Attention Deficit Hyperactivity Disorder (ADHD) market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Italy Attention Deficit Hyperactivity Disorder (ADHD) market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE UK Attention Deficit Hyperactivity Disorder (ADHD) market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE FranceAttention Deficit Hyperactivity Disorder (ADHD) market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of the Europe Attention Deficit Hyperactivity Disorder (ADHD) market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) market share analysis by country, 2018
  • FIGURE India Attention Deficit Hyperactivity Disorder (ADHD) market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE China Attention Deficit Hyperactivity Disorder (ADHD) market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Japan Attention Deficit Hyperactivity Disorder (ADHD) market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE South Korea Attention Deficit Hyperactivity Disorder (ADHD) market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Singapore Attention Deficit Hyperactivity Disorder (ADHD) market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of APACAttention Deficit Hyperactivity Disorder (ADHD) market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Attention Deficit Hyperactivity Disorder (ADHD) market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin AmericaAttention Deficit Hyperactivity Disorder (ADHD) market share analysis by country, 2018
  • FIGURE BrazilAttention Deficit Hyperactivity Disorder (ADHD) market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Mexico Attention Deficit Hyperactivity Disorder (ADHD) market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Argentina Attention Deficit Hyperactivity Disorder (ADHD) market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of LATAM Attention Deficit Hyperactivity Disorder (ADHD) market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) market share analysis by country, 2018
  • FIGURE Saudi Arabia Attention Deficit Hyperactivity Disorder (ADHD) market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE United Arab Emirates Attention Deficit Hyperactivity Disorder (ADHD) market size, forecast and trend analysis, 2015 to 2026 (USD Million)